Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/55455
Tipo de documento
ArtigoDireito Autoral
Acesso aberto
Coleções
- INI - Artigos de Periódicos [3535]
Metadata
Mostrar registro completo
DEVELOPMENT AND VALIDATION OF A RISK SCORE FOR PREDICTING DEATH IN CHAGAS' HEART DISEASE
Autor(es)
Afiliação
Anis Rassi Hospital. Division of Cardiology. Goiânia, GO, Brazil.
Anis Rassi Hospital. Division of Cardiology. Goiânia, GO, Brazil.
Wake Forest University School of Medicine. Section of Cardiology. Winston-Salem. NC, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Anis Rassi Hospital. Division of Cardiology. Goiânia, GO, Brazil.
Anis Rassi Hospital. Division of Cardiology. Goiânia, GO, Brazil.
Anis Rassi Hospital. Division of Cardiology. Goiânia, GO, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Universidade de São Paulo. Faculdade de Medicina. Instituto do Coração. São Paulo, SP, Brasil.
Anis Rassi Hospital. Division of Cardiology. Goiânia, GO, Brazil.
Wake Forest University School of Medicine. Section of Cardiology. Winston-Salem. NC, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Anis Rassi Hospital. Division of Cardiology. Goiânia, GO, Brazil.
Anis Rassi Hospital. Division of Cardiology. Goiânia, GO, Brazil.
Anis Rassi Hospital. Division of Cardiology. Goiânia, GO, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Universidade de São Paulo. Faculdade de Medicina. Instituto do Coração. São Paulo, SP, Brasil.
Resumo em Inglês
Background: Chagas' disease is an important health problem in Latin America, and cardiac involvement is associated with substantial morbidity and mortality. We developed a model to predict the risk of death in patients with Chagas' heart disease.
Methods: We retrospectively evaluated 424 outpatients from a regional Brazilian cohort. The association of potential risk factors with death was tested by Cox proportional-hazards analysis, and a risk score was created. The model was validated in 153 patients from a separate community hospital.
Results: During a mean follow-up of 7.9 years, 130 patients in the development cohort died. Six independent prognostic factors were identified, and each was assigned a number of points proportional to its regression coefficient: New York Heart Association class III or IV (5 points), evidence of cardiomegaly on radiography (5 points), left ventricular systolic dysfunction on echocardiography (3 points), nonsustained ventricular tachycardia on 24-hour Holter monitoring (3 points), low QRS voltage on electrocardiography (2 points), and male sex (2 points). We calculated risk scores for each patient and defined three risk groups: low risk (0 to 6 points), intermediate risk (7 to 11 points), and high risk (12 to 20 points). In the development cohort, the 10-year mortality rates for these three groups were 10 percent, 44 percent, and 84 percent, respectively. In the validation cohort, the corresponding mortality rates were 9 percent, 37 percent, and 85 percent. The C statistic for the point system was 0.84 in the development cohort and 0.81 in the validation cohort.
Conclusions: A simple risk score was developed to predict death in Chagas' heart disease and was validated in an independent cohort.
Editor
Massachusetts Medical Society
Referência
RASSI JUNIOR, Anis et al. Development and Validation of a Risk Score for Predicting Death in Chagas’ Heart Disease. The New England Journal of Medicine, v. 355, n. 8, p. 799-808, 2006.DOI
10.1056/NEJMoa053241ISSN
0028-4793Itens relacionados
Apresentado os itens relacionados pelo título, autor e assunto.
-
SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease - 2023
Marin-Neto, José Antonio et al. | Data do documento: 2023Em 2021, por iniciativa de seu então presidente, Dr. Marcelo Queiroga Cartaxo Lopes, a Sociedade Brasileira de Cardiologia (SBC) nos comissionou para a coordenação dos trabalhos, visando à elaboração da nova diretriz ... -
Impacto do controle químico extensivo de Triatoma infestans sobre a incidência de casos agudos e a prevalência de doença de Chagas: o exemplo de Montalvânia, Minas Gerais
Rassi, Anis et al. | Data do documento: 2003A partir da emergência de um surto de casos agudos de doença de Chagas em Montalvânia, norte de Minas Gerais, Brasil, e da implantação do controle triatomínico com inseticidas, verifica-se pronta e conseqüente desaparição ... -
Randomized Trial of Benznidazole for Chronic Chagas Cardiomyopathy
Morillo, Carlos A. et al. | Data do documento: 2015
Compartilhar